Clorox (CLX) Common Equity (2009 - 2026)

Clorox's Common Equity history runs 18 years deep, the most recent figure standing at -$67.0 million for Q1 2026.

• In Q1 2026, Common Equity fell 135.26% year-over-year to -$67.0 million; the TTM figure through Mar 2026 stood at -$67.0 million (down 135.26% YoY), while the FY2025 annual figure was $482.0 million, down 2.03% from the prior year.
• Common Equity was -$67.0 million for Q1 2026 at Clorox, down from $35.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $729.0 million in Q2 2022 to a low of -$67.0 million in Q1 2026.
• Historically, Common Equity has averaged $298.3 million across 5 years, with a median of $224.0 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Common Equity soared 70.99% in 2024, then tumbled 135.26% in 2026.
• A 5-year view of Common Equity shows it stood at $491.0 million in 2022, then plunged by 55.6% to $218.0 million in 2023, then sank by 44.5% to $121.0 million in 2024, then plunged by 71.07% to $35.0 million in 2025, then tumbled by 291.43% to -$67.0 million in 2026.
• The last three Common Equity figures came in at -$67.0 million (Q1 2026), $35.0 million (Q4 2025), and $138.0 million (Q3 2025), per Business Quant data.